Next Article in Journal
Structural Basis of Native CXCL7 Monomer Binding to CXCR2 Receptor N-Domain and Glycosaminoglycan Heparin
Next Article in Special Issue
A Review on Ubiquitination of Neurotrophin Receptors: Facts and Perspectives
Previous Article in Journal
The Diverse Roles of Microglia in the Neurodegenerative Aspects of Central Nervous System (CNS) Autoimmunity
Previous Article in Special Issue
The Regulations of Deubiquitinase USP15 and Its Pathophysiological Mechanisms in Diseases
Article Menu
Issue 3 (March) cover image

Export Article

Open AccessCase Report
Int. J. Mol. Sci. 2017, 18(3), 505; doi:10.3390/ijms18030505

High Levels of Serum Ubiquitin and Proteasome in a Case of HLA-B27 Uveitis

1
Eye Clinic of Multidisciplinary Department of Medical, Surgical and Dental Sciences Department, Second University of Naples, Naples 80131, Italy
2
Department of Experimental Medicine, Section of Pharmacology, Second University of Naples, Naples 80138, Italy
*
Author to whom correspondence should be addressed.
Academic Editor: Nobuhiro Nakamura
Received: 13 January 2017 / Revised: 17 February 2017 / Accepted: 23 February 2017 / Published: 26 February 2017
(This article belongs to the Special Issue Ubiquitin System)
View Full-Text   |   Download PDF [796 KB, uploaded 26 February 2017]   |  

Abstract

In this paper, the authors describe a case of high serum levels of ubiquitin and proteasome in a woman under an acute attack of autoimmune uveitis. The woman was 52 years old, diagnosed as positive for the Human leukocyte antigen-B27 gene, and came to our observation in January 2013 claiming a severe uveitis attack that involved the right eye. During the acute attack of uveitis, this woman had normal serum biochemical parameters but higher levels of serum ubiquitin and proteasome 20S subunit, with respect to a healthy volunteer matched for age and sex. These levels correlated well with the clinical score attributed to uveitis. After the patient was admitted to therapy, she received oral prednisone in a de-escalation protocol (doses from 50 to 5 mg/day) for four weeks. Following this therapy, she had an expected reduction of clinical signs and score for uveitis, but concomitantly she had a reduction of the serum levels of ubiquitin, poliubiquitinated proteins (MAb-FK1) and proteasome 20S activity. Therefore, a role for ubiquitin and proteasome in the development of human autoimmune uveitis has been hypothesized. View Full-Text
Keywords: autoimmune uveitis; ubiquitin; proteasome; prednisone autoimmune uveitis; ubiquitin; proteasome; prednisone
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Rossi, S.; Gesualdo, C.; Maisto, R.; Trotta, M.C.; Di Carluccio, N.; Brigida, A.; Di Iorio, V.; Testa, F.; Simonelli, F.; D’Amico, M.; Di Filippo, C. High Levels of Serum Ubiquitin and Proteasome in a Case of HLA-B27 Uveitis. Int. J. Mol. Sci. 2017, 18, 505.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top